Researcher
Philip Van Damme
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Cell death, Behavioural neuroscience
- Disciplines (KU Leuven):Neurological and neuromuscular diseases
- See also: Philip Van Damme (Flanders Institute for Biotechnology)
Affiliations
- Van Den Bosch Lab (Research group)
Member
From1 Jan 2017 → Today - Laboratory for Neurobiology (VIB-KU Leuven) (Lab)
Member
From1 Jan 2012 → Today - Research Group Experimental Neurology (Division)
Member
From1 Oct 2000 → 31 Dec 2011
Projects
1 - 10 of 49
- Towards mechanistic biomarkers for amyotrophic lateral sclerosisFrom1 Jan 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Mapping the microglial heterogeneity in C9orf72-ALS and sporadic ALS using single cell profilingFrom1 Nov 2023 → TodayFunding: BOF - postdoctoral mandates
- A multi-modal and longitudinal approach to study the neurobiological underpinnings of disease onset and progression in genetic ALS variants: from presymptomatic to symptomatic disease stages.From1 Oct 2023 → TodayFunding: FWO junior postdoctoral fellowship
- HDAC6 inhibition restores TDP-43 pathology and axonal transport defects in human motor neurons with TARDBP mutationsFrom19 Apr 2023 → 31 Dec 2023Funding: Foundations, funds and other with scientific goal
- Measuring brain activation non-invasively in freely moving healthy and neuropsychiatric human populations using functional near-infrared spectroscopy (fNIRS)From1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- Investigating the role of cilia dysfunction in Amyotrophic Lateral SclerosisFrom1 Oct 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Mechanisms of motor neuron degeneration in amyotrophic lateral sclerosis (ALS): cell death pathways and/or aberrant communication between cell body and neuromuscular junctionsFrom1 Oct 2022 → TodayFunding: BOF - projects
- A multi-modal approach to study C9orf72-mediated diseaseFrom16 May 2022 → 15 May 2023Funding: BOF - postdoctoral mandates
- Biomarkers in asymptomatic carriers of ALS-related mutationsFrom1 Apr 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Understanding lysosomal dysfunction in the frontotemporal dementiaamyotrophic lateral sclerosis spectrum of neurodegenerative disorders.From1 Jan 2022 → TodayFunding: FWO research project (including WEAVE projects)
Publications
201 - 210 of 340
- C9orf72 expansion differentially affects males with spinal onset amyotrophic lateral sclerosis(2017)
Authors: Wim Robberecht, Philip Van Damme
Pages: 281 - Negative commercial screening test for paraneoplastic antibodies in a case of opsoclonus(2017)
Authors: Nicolas Vandenbussche, Catherine Cassiman, Maarten Schrooten, Benjamin Gille, Xavier Bossuyt, Thierry Vincent, Philip Van Damme, Koen Poesen
- Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patients(2017)
Authors: Matthieu Moisse, Mathieu Vandenbulcke, Rik Vandenberghe, Philip Van Damme
Pages: 177 - TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis(2017)
Authors: Rik Vandenberghe, Wim Robberecht, Philip Van Damme
Pages: 297 - 309 - ATXN2 trinucleotide repeat length correlates with risk of ALS(2017)
Authors: Philip Van Damme, Wim Robberecht
Pages: 178 - Phase separation of C9orf72 dipeptide repeats perturbs stress granule dynamics(2017)
Authors: Steven Boeynaems, Elke Bogaert, Mathias De Decker, Thomas Vercruysse, Dirk Daelemans, Joost Schymkowitz, Frederic Rousseau, Wim Robberecht, Philip Van Damme, Ludo Van Den Bosch
Pages: 1044 - 1055 - Negative commercial screening test for paraneoplastic antibodies in a case of opsoclonus(2017)
Authors: Catherine Cassiman, Maarten Schrooten, Benjamin Gille, Xavier Bossuyt, Philip Van Damme, Koen Poesen
- IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients(2017)
Authors: Philip Van Damme
Pages: 104 - 115 - Prognostic value of clinical and electrodiagnostic parameters at time of diagnosis in patients with amyotrophic lateral sclerosis(2017)
Authors: Maarten Schrooten, Kristl Claeys, Wim Robberecht, Steffen Fieuws, Philip Van Damme
Pages: 341 - 350 - Prognostic value of clinical and electrodiagnostic parameters at time of diagnosis in patients with amyotrophic lateral sclerosis(2017)
Authors: W Reniers, Maarten Schrooten, Kristl Claeys, P Tilkin, A D'Hondt, D Van Reijen, G Couwelier, N Lamaire, Wim Robberecht, S Fieuws, et al.
Pages: 341 - 350